Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Falzon

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Bulletin of the World Health Organization|January 2, 2015
Pharmacovigilance and tuberculosis: applying the lessons of thioacetazoneDennis Falzon, Geraldine Hill, Shanthi N Pal, et al.
European Journal of Public Health|April 8, 2003
Safe water for the Aral Sea Area: could it get any worse?Ian Small, Dennis Falzon, Joost B W van der Meer, et al.
The European Respiratory Journal|December 11, 2012
Multidrug-resistant tuberculosis in children: evidence from global surveillanceMatteo Zignol, Charalambos Sismanidis, Dennis Falzon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 1, 2025
Early adopters of 6-month levofloxacin as rifampicin-resistant tuberculosis preventive treatment regimen in the WHO European Region, 2023Irina Felker, Alexandra Solovyeva, Ana Ciobanu, et al.
The European Respiratory Journal|December 2, 2015
Numbers needed to treat to prevent tuberculosisAlberto Matteelli, Knut Lönnroth, Haileyesus Getahun, et al.
The Lancet. Infectious Diseases|June 8, 2013
Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance dataDennis Falzon, Ernesto Jaramillo, Fraser Wares, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2011
Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testingMatteo Zignol, Wayne van Gemert, Dennis Falzon, et al.
Plos Medicine|October 19, 2019
Advances in clinical trial design for development of new TB treatments-Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and VietnamGrania Brigden, Nguyen Viet Nhung, Alena Skrahina, et al.
The European Respiratory Journal|November 11, 2017
Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectivesDennis Falzon, Giovanni Battista Migliori, Ernesto Jaramillo, et al.
Plos One|March 5, 2013
A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatmentChunling Lu, Qing Liu, Aartik Sarma, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Bulletin of the World Health Organization|January 2, 2015
Pharmacovigilance and tuberculosis: applying the lessons of thioacetazoneDennis Falzon, Geraldine Hill, Shanthi N Pal, et al.
European Journal of Public Health|April 8, 2003
Safe water for the Aral Sea Area: could it get any worse?Ian Small, Dennis Falzon, Joost B W van der Meer, et al.
The European Respiratory Journal|December 11, 2012
Multidrug-resistant tuberculosis in children: evidence from global surveillanceMatteo Zignol, Charalambos Sismanidis, Dennis Falzon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 1, 2025
Early adopters of 6-month levofloxacin as rifampicin-resistant tuberculosis preventive treatment regimen in the WHO European Region, 2023Irina Felker, Alexandra Solovyeva, Ana Ciobanu, et al.
The European Respiratory Journal|December 2, 2015
Numbers needed to treat to prevent tuberculosisAlberto Matteelli, Knut Lönnroth, Haileyesus Getahun, et al.
The Lancet. Infectious Diseases|June 8, 2013
Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance dataDennis Falzon, Ernesto Jaramillo, Fraser Wares, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2011
Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testingMatteo Zignol, Wayne van Gemert, Dennis Falzon, et al.
Plos Medicine|October 19, 2019
Advances in clinical trial design for development of new TB treatments-Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and VietnamGrania Brigden, Nguyen Viet Nhung, Alena Skrahina, et al.
The European Respiratory Journal|November 11, 2017
Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectivesDennis Falzon, Giovanni Battista Migliori, Ernesto Jaramillo, et al.
Plos One|March 5, 2013
A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatmentChunling Lu, Qing Liu, Aartik Sarma, et al.
Pageof 11